Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-07 |
mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.16 | 9e-07 |
mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-06 |
mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.16 | 4e-06 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-06 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.14 | 9e-06 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.16 | 4e-05 |